National Wildlife Fed'n v. Secretary of Health & Human Servs.

The court holds that the Food and Drug Administration's (FDA's) decision not to issue an interim action level or tolerance setting acceptable levels of dioxin contamination for human consumption of Great Lakes fish is supported by substantial evidence and accords with the Federal Food, Drug, and Cosmetic Act. The FDA considered the relevant data in its decision not to issue an interim level or tolerance and calculated the risks to the public of contracting cancer from exposure to fish with dioxin residues. Moreover, the agency issued an advisory standard for consumption of dioxin-contaminated Great Lakes sports fish, which it, in its discretion, determined to be sufficient.